US Obesity Rates Hit Record High Amid New Drug Hope
New CDC data reveals American obesity rates have hit unprecedented levels, while revolutionary GLP-1 medications like Wegovy and Zepbound show promising results in combating the epidemic.
New CDC data reveals American obesity rates have hit unprecedented levels, while revolutionary GLP-1 medications like Wegovy and Zepbound show promising results in combating the epidemic.
Exclusive analysis reveals how Britain's growing obesity epidemic is pushing the NHS toward an impossible choice between routine care and weight-related treatments as waiting lists hit record highs.
Exclusive: British surgeons pioneer revolutionary robotic prostate procedures that take just 10 minutes, offering new hope for thousands stuck on NHS waiting lists. Discover how this medical breakthrough is transforming cancer care across the UK.
Harry Moseley's heartbreaking story highlights growing fears over NHS treatment delays as young father dies after multiple postponed appointments during pandemic.
Shocking new research reveals the UK's favourite smoothing hair treatment contains up to 5 times the legal formaldehyde limit, posing serious cancer risks to clients and stylists.
Groundbreaking research from Lund University shows obesity significantly increases risk for numerous cancers including leukaemia, thyroid and breast cancer, with UK health experts calling for urgent action.
Groundbreaking research exposes how obesity has become the primary driver behind rising cancer rates in older adults, with stark warnings for UK healthcare systems.
High street pharmacy chain Boots has suspended its popular 'fat jab' weight loss injection service following overwhelming demand and supply shortages, leaving thousands of customers seeking alternatives.
Groundbreaking research exposes Australia's alarming obesity divide, with detailed analysis revealing which suburbs are winning and losing the battle of the bulge.
Breakthrough drug Retatrutide demonstrates remarkable 24% weight loss in clinical trials, potentially revolutionising obesity treatment in the UK healthcare landscape.
New data reveals America's obesity epidemic has worsened dramatically, with 22 states reaching unprecedented levels. Health experts warn of severe consequences for healthcare systems and national wellbeing.
The NHS is launching an ambitious programme using weight-loss medications like Mounjaro to tackle obesity-related conditions and reduce hospital waiting times across the UK.
Groundbreaking research reveals Mounjaro injections could revolutionise obesity treatment by targeting food addiction mechanisms in the brain, offering new hope for millions struggling with compulsive eating.
A 35-year-old woman shares her incredible 5-stone weight loss journey using diabetes drug Mounjaro, revealing the uncomfortable side effect affecting thousands and the cheap gadget that provided relief.
Groundbreaking weight loss injections Wegovy and Mounjaro are transforming obesity treatment in the UK, offering new hope for thousands struggling with weight management through both NHS and private healthcare providers.
Groundbreaking research shows obesity injections like Mounjaro and Wegovy deliver unprecedented weight loss results, potentially transforming NHS treatment approaches and offering new hope for millions struggling with weight management.
Groundbreaking research reveals nearly 5% of UK adults are turning to revolutionary weight loss injections like Wegovy and Mounjaro, with overwhelming majority paying privately amid NHS supply constraints.
A determined mother from the UK has shed over 10 stone using diabetes medication Mounjaro, completely transforming her life and health in an inspiring weight loss journey.
Groundbreaking research shows weight loss injections like Wegovy and Ozempic do more than help shed pounds - they're linked to significant reductions in premature death from cancer, heart disease and diabetes.
New medical research reveals the sobering reality for patients discontinuing popular weight loss injections like Ozempic and Wegovy, with most regaining significant weight within months.
Exclusive: Costco pharmacies begin selling revolutionary weight loss injections Wegovy and Ozempic at competitive prices, making groundbreaking treatments more accessible across Britain.
Broadmoor Hospital prescribes controversial weight-loss injections including Ozempic to dangerous criminals battling obesity, sparking ethical debate about taxpayer-funded treatments for serious offenders.
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.
A woman's astonishing account reveals how dramatic weight loss transformed her social experience, exposing society's hidden bias toward thinner bodies and raising questions about 'pretty privilege'.
The NHS is poised to prescribe diabetes medication Mounjaro for weight loss in a groundbreaking move that could help millions of Britons struggling with obesity. Health Secretary Wes Streeting announces major expansion of weight management services.
Eli Lilly accuses the UK of having Europe's most challenging drug pricing system, threatening patient access to new medicines like Mounjaro amid ongoing NHS negotiations.
Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.
New generation weight-loss medications are doing more than suppress appetite; they're fundamentally altering our psychological and emotional connections to eating, raising profound questions for individuals and society.
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.